The fusion of the androgen-regulated serine protease TMPRSS2 with the ETS family transcription factor ERG along with the inactivating rearrangements of the tumor suppressor gene phosphatase and tensin homolog (PTEN) are among the most common genetic alterations in prostate cancer [5]. The gene discussed is PTEN; the disease is prostate carcinoma.